In addition, APOC3 appears to hold an important role as a CVD risk factor and mediator in people with diabetes, at least in the case of type 1 diabetes, in which plasma triglyceride levels are often within the optimal (<100 mg/dl) to borderline (100–150 mg/dl) range. Here, APOC3 is linked to type 1 diabetes mellitus.